Product Program year 2025 Source: CMS Open Payments

Gelport Laparoscopic System

Device Specialty Access

PDI 00607915118303

Open in the dashboard

General payments

$406,914

432 payments

Research payments

$0

0 payments

Through program year 2025, $406,914 in general payments and $0 in research payments were reported against Gelport Laparoscopic System (Specialty Access).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $222,850 234
2024 General $79,523 115
2023 General $45,697 42
2022 General $45,618 30
2021 General $13,227 11

Breakdown

Who paid General payments · program years 2021–2025
  1. Applied Medical Resources Corporation $406,914 432 payments
Top recipients General payments · program year 2025
  1. David Rosen Colon & Rectal Surgery · Cleveland, OH $35,456 16% · 45 payments
  2. Matthew Albert Colon & Rectal Surgery · Altamonte Springs, FL $31,039 14% · 32 payments
  3. Jennifer Paruch Colon & Rectal Surgery · New Orleans, LA $20,003 9% · 14 payments
  4. Adventhealth Orlando Teaching hospital · FL $13,534 6% · 1 payment
  5. Lilian Chen Colon & Rectal Surgery · Boston, MA $12,899 6% · 16 payments

The top 5 of 54 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Colon & Rectal Surgery $196,313 94% · 30 practitioners
  2. Surgery $10,331 5% · 15 practitioners
  3. Trauma Surgery Surgery $703 <1% · 1 practitioner
  4. Obstetrics & Gynecology $328 <1% · 1 practitioner
  5. Internal Medicine $188 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $77,929 35% · 13 recipients
  2. Ohio $38,593 17% · 4 recipients
  3. Massachusetts $32,818 15% · 5 recipients
  4. Louisiana $20,003 9% · 1 recipient
  5. California $14,087 6% · 3 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

432 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record